IDENTIFICATION OF A NOVEL NONSENSE MUTATION AND A MISSENSE SUBSTITUTION IN THE VASOPRESSIN-NEUROPHYSIN-II GENE IN 2 SPANISH KINDREDS WITH FAMILIAL NEUROHYPOPHYSEAL DIABETES-INSIPIDUS
B. Calvo et al., IDENTIFICATION OF A NOVEL NONSENSE MUTATION AND A MISSENSE SUBSTITUTION IN THE VASOPRESSIN-NEUROPHYSIN-II GENE IN 2 SPANISH KINDREDS WITH FAMILIAL NEUROHYPOPHYSEAL DIABETES-INSIPIDUS, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 995-997
Familial neurohypophyseal diabetes insipidus (FNDI) is an autosomal do
minant disease caused by deficiency in the antidiuretic hormone argini
ne vasopressin (AVP) encoded by the AVP-neurophysin II (AVP-NPII) gene
on chromosome 20p13. In this study, we analyzed two families with FND
I using direct automated fluorescent, solid phase, single-stranded DNA
sequencing of PCR-amplified AVP-NPII DNA. In one of the families, aff
ected individuals presented a novel nonsense mutation in exon 3 of the
gene, consisting in a G to T transition at nucleotide 2101, which pro
duces a stop signal in codon 82 (Glu) Of NPII. The premature terminati
on eliminates part of the C-terminal domain of NPII, including a cyste
ine residue in position 85, which could be involved in the correct fol
ding of the prohormone. In the second family, a G279A substitution at
position -1 of the signal peptide was observed in all affected individ
uals. This missense mutation, which replaces Ala with Thr, is frequent
among FNDI patients and is thought to reduce the efficiency of cleava
ge by signal peptidases.